ストックスクリーナーアプリを入手
5.32
9.22%
-0.54
前日終値:
$5.86
開ける：
$5.76
24時間の取引高:
448.80K
Relative Volume:
0.69
時価総額：
$248.50M
収益：
$121.14M
当期純損益:
$-32.33M
株価収益率:
-6.186
EPS:
-0.86
ネットキャッシュフロー:
$-22.69M
1週間 パフォーマンス:
-20.83%
1か月 パフォーマンス:
-9.52%
6か月 パフォーマンス:
+16.92%
1年 パフォーマンス:
-30.46%
1日の値動き範囲:
$5.3014
$5.76
1週間の範囲:
$5.31
$6.67
52週間の値動き範囲:
$4.05
$8.77
Quanterix Corp Stock (QTRX) Company Profile
Compare QTRX vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
QTRX
Quanterix Corp
|
5.32 | 273.73M | 121.14M | -32.33M | -22.69M | -0.86 |
|
ABT
Abbott Laboratories
|
111.34 | 196.53B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
371.40 | 146.14B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
92.94 | 122.74B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
71.33 | 107.15B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
84.02 | 49.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Quanterix Corp Stock (QTRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-11 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2024-02-01 | 開始されました | Scotiabank | Sector Outperform |
| 2023-09-25 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2023-08-08 | アップグレード | SVB Securities | Market Perform → Outperform |
| 2023-05-23 | アップグレード | Goldman | Neutral → Buy |
| 2022-08-15 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2022-08-09 | ダウングレード | Cowen | Outperform → Market Perform |
| 2022-08-09 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2022-03-02 | アップグレード | Goldman | Sell → Neutral |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-06-04 | 開始されました | Goldman | Sell |
すべてを表示
Quanterix Corp (QTRX) 最新ニュース
Quanterix at TD Cowen Conference: Strategic Growth and Diagnostics Focus - Investing.com
Quanterix Corporation (NASDAQ:QTRX) Q4 2025 Earnings Call Transcript - Insider Monkey
Quanterix Q4 Earnings Call Highlights - Defense World
Quanterix (QTRX) Revenue Growth Keeps Losses Central To Bulls’ Long-Term Narrative - simplywall.st
Earnings call transcript: Quanterix Q4 2025 shows revenue beat but EPS miss - Investing.com Australia
Earnings call transcript: Quanterix Q4 2025 shows revenue beat but EPS miss By Investing.com - Investing.com South Africa
Quanterix Corp (QTRX) Q4 2025 Earnings Call Highlights: Revenue Surge Amidst Strategic Shifts - GuruFocus
Quanterix Q4 2025 Earnings Call Transcript - MarketBeat
Quanterix Q4 2025 slides: cost cuts drive path to cash flow breakeven - Investing.com South Africa
Quanterix Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Quanterix Corporation (QTRX) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
Quanterix (QTRX) Exceeds Q4 Revenue Expectations with Strong Per - GuruFocus
Quanterix Corporation (QTRX) Releases Q4 2025 Earnings: Revenue Beats but EPS Slightly Misses - Quiver Quantitative
Quanterix earnings missed by $0.06, revenue topped estimates - Investing.com
Quanterix (NASDAQ:QTRX) Releases Earnings Results, Misses Expectations By $0.11 EPS - MarketBeat
Quanterix Corporation 8-K Filing Analysis - TradingView
Quanterix Earnings Report: Q4 Overview - Benzinga
Alzheimer’s blood test heads to 15,000 community events a year - Stock Titan
Quanterix (QTRX) Set to Announce Q4 Earnings with Revenue Growth Expected - GuruFocus
Quanterix (QTRX) to Release Earnings on Monday - Defense World
Quanterix Corp expected to post a loss of 45 cents a shareEarnings Preview - TradingView
Earnings Outlook For Quanterix - Benzinga
Quanterix Corp (QTRX) Q4 2025 Earnings Report Preview: What To L - GuruFocus
Quanterix to Participate in Upcoming Investor Conferences - ChartMill
Envestnet Asset Management Inc. Grows Holdings in Quanterix Corporation $QTRX - Defense World
QTRX Should I Buy - Intellectia AI
Quanterix (QTRX) Expected to Announce Quarterly Earnings on Monday - MarketBeat
Investors can hear Quanterix 2025 results discussed on Mar. 2 call - Stock Titan
Quanterix (NASDAQ:QTRX) Shares Up 0.7%Time to Buy? - MarketBeat
Quanterix Submits FDA 510(k) for Multi-Analyte Alzheimer’s Blood Test - Clinical Lab Products
With 68% ownership, Quanterix Corporation (NASDAQ:QTRX) boasts of strong institutional backing - Yahoo Finance
Quanterix submits FDA 510(k) for multi-analyte Alzheimer's blood test - MSN
Aug Swings: Should value investors consider Quanterix CorporationGlobal Markets & Growth Focused Entry Point Reports - baoquankhu1.vn
Quanterix Submits FDA 510(k) for Multi-Analyte Alzheimer's Blood Test - TradingView
Quanterix (QTRX) Submits Alzheimer's Blood Test for FDA Approval - GuruFocus
Quanterix submits FDA 510(k) for multi-analyte Alzheimer’s blood test - Investing.com
Blood test to spot Alzheimer’s earlier moves to FDA review - Stock Titan
What’s the MACD signal for Quanterix CorporationWeekly Volume Report & Long-Term Growth Stock Strategies - mfd.ru
Quanterix (NASDAQ:QTRX) Trading Down 3.6%Here's What Happened - MarketBeat
Quanterix (NASDAQ:QTRX) Trading Down 3.6% – Here’s What Happened - Defense World
Former Illumina Executive Moves Into Quanterix’s Corner Office - Medical Product Outsourcing
Study finds multi-biomarker approach improves Alzheimer’s risk assessment - Investing.com
15-year brain study: blood test combo better flags Alzheimer’s risk - Stock Titan
Quanterix Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(4) - marketscreener.com
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
The Truth About Quanterix Corp (QTRX): Tiny Biotech, Massive Hype – But Is It Worth Your Money? - AD HOC NEWS
Big Money Moves: Is Quanterix Corporation stock overvalued by current metricsWeekly Trade Analysis & Community Consensus Trade Alerts - Bộ Nội Vụ
Does Quanterix Corporation stock benefit from AI growthWeekly Stock Summary & Fast Entry Momentum Alerts - baoquankhu1.vn
Illumina names former NIH official as medical chief; commercial chief joins Quanterix - Seeking Alpha
Canaccord Genuity reiterates Hold rating on Quanterix stock By Investing.com - Investing.com Nigeria
Canaccord Genuity reiterates Hold rating on Quanterix stock - Investing.com
Quanterix Corp (QTRX) 財務データ
収益
当期純利益
現金流量
EPS
Quanterix Corp (QTRX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| WALT DAVID R | Director |
Jun 13 '25 |
Buy |
6.14 |
123,990 |
760,803 |
1,866,933 |
| WALT DAVID R | Director |
Jun 12 '25 |
Buy |
6.23 |
36,010 |
224,166 |
1,742,943 |
| Toloue Masoud | President & CEO |
Jun 09 '25 |
Buy |
5.42 |
45,900 |
248,723 |
518,922 |
| WALT DAVID R | Director |
Jun 06 '25 |
Buy |
5.43 |
131,869 |
716,576 |
1,628,802 |
| WALT DAVID R | Director |
Jun 09 '25 |
Buy |
5.34 |
78,131 |
417,220 |
1,706,933 |
| DONNELLY WILLIAM P | Director |
Jun 06 '25 |
Buy |
5.44 |
93,113 |
506,348 |
139,094 |
1.78%
大文字化:
|
ボリューム (24 時間):